OpenURL Connection Search

Select item for more details and to access through your institution.

The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes.
Published in:
European Journal of Endocrinology, 2014, v. 170, n. 4, p. 565, doi. 10.1530/EJE-13-0639
By:
- Van Raalte, Daniäl H.;
- van Genugten, Renate E.;
- Eliasson, Björn;
- Möller-Goede, Diane L.;
- Mari, Andrea;
- Tura, Andrea;
- Wilson, Craig;
- Fleck, Penny;
- Taskinen, Marja R.;
- Smith, Ulf;
- Diamant, Michaela
Publication type:
Article
Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial.
Published in:
European Journal of Endocrinology, 2014, v. 170, n. 3, p. 429, doi. 10.1530/EJE-13-0610
By:
- van Genugten, Renate E.;
- van Raalte, Daniël H.;
- Muskiet, Marcel H.;
- Heymans, Martijn W.;
- Pouwels, Petra J. W.;
- Ouwens, D. Margriet;
- Mari, Andrea;
- Diamant, Michaela
Publication type:
Article
Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity.
Published in:
BMC Medical Genomics, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s12920-015-0096-y
By:
- van der Pouw Kraan, Tineke C. T. M.;
- Chen, Weena J.;
- Bunck, Mathijs C. M.;
- van Raalte, Daniel H.;
- van der Zijl, Nynke J.;
- van Genugten, Renate E.;
- van Bloemendaal, Liselotte;
- Baggen, Josefien M.;
- Serné, Erik H.;
- Diamant, Michaela;
- Horrevoets, Anton J. G.
Publication type:
Article
Effects of Sex and Hormone Replacement Therapy Use on the Prevalence of Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance in Subjects With a Family History of Type 2 Diabetes.
Published in:
Diabetes, 2006, v. 55, n. 12, p. 3529, doi. 10.2337/db06-0577
By:
- van Genugten, Renate E.;
- Utzschneider, Kristina M.;
- Tong, Jenny;
- Gerchman, Fernando;
- Zraika, Sakeneh;
- Udayasankar, Jayalakshmi;
- Boyko, Edward J.;
- Fujimoto, Wilfred Y.;
- Kahn, Steven E.
Publication type:
Article
Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.
Published in:
2011
By:
- van Raalte DH;
- van Genugten RE;
- Linssen MM;
- Ouwens DM;
- Diamant M;
- van Raalte, Daniël H;
- van Genugten, Renate E;
- Linssen, Margot M L;
- Ouwens, D Margriet;
- Diamant, Michaela
Publication type:
journal article
Glucagon-Like Peptide. 1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans.
Published in:
Diabetes Care, 2011, v. 34, n. 2, p. 412, doi. 10.2337/dc10-1677
By:
- VAN RAALTE, DANIËL H.;
- VAN GENUGTEN, RENATE E.;
- LINSSEN, MARGOT M. L.;
- OUWENS, D. MARGRIET;
- DIAMANT, MICHAELA
Publication type:
Article

Found: 6

The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes.

Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial.

Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity.

Effects of Sex and Hormone Replacement Therapy Use on the Prevalence of Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance in Subjects With a Family History of Type 2 Diabetes.

Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.

Glucagon-Like Peptide. 1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans.